[{"NetIncomeLoss_1_Q1_USD":-52739943.0,"GeneralAndAdministrativeExpense_1_Q1_USD":52583639.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":80946450.0,"RestrictedCashCurrent_0_Q1_USD":1400000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":3439868.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q1_pure":0.949,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q1_USD":20.03,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":246545.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":116269249.0,"Depreciation_1_Q1_USD":127008.0,"PaymentsToAcquireInvestments_1_Q1_USD":34147683.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_1_Q1_USD":16.3,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1_Q1_shares":511932.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q1_USD":1431658.0,"AssetsCurrent_0_Q1_USD":649100443.0,"OperatingLeaseExpense_1_Q1_USD":800000.0,"CommonStockSharesIssued_0_Q1_shares":81133849.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":1189535.0,"StockIssuedDuringPeriodValueIssuedForServices_1_Q1_USD":53542.0,"Assets_0_Q1_USD":674488568.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-234039.0,"ShareBasedCompensation_1_Q1_USD":6778436.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q1_USD":18.72,"OperatingLeaseRightOfUseAsset_0_Q1_USD":23430703.0,"MoneyMarketFundsAtCarryingValue_0_Q1_USD":83600000.0,"OperatingLeaseLiability_0_Q1_USD":28200000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-234039.0,"AccountsReceivableNetCurrent_0_Q1_USD":13661992.0,"IncomeTaxExpenseBenefit_1_Q1_USD":5000.0,"CommonStockValue_0_Q1_USD":8113.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1_Q1_shares":20717.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":154000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":1431658.0,"AvailableForSaleSecuritiesCurrent_0_Q1_USD":481984786.0,"IncreaseDecreaseInInventories_1_Q1_USD":523008.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":13491620.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-52973982.0,"AccruedEmployeeBenefitsCurrent_0_Q1_USD":11915893.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":3219132.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.0082,"OtherAssetsNoncurrent_0_Q1_USD":86084.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":129979888.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":22637100.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_1_Q1_USD":150416932.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1601739075.0,"Liabilities_0_Q1_USD":62338810.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q1_USD":481738000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":258929.0,"CommonStockSharesAuthorized_0_Q1_shares":100000000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":2897409.0,"CommonStockSharesOutstanding_0_Q1_shares":81133849.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q1_shares":5890156.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue_0_Q1_USD":243200000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":4163557.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-52734943.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":6778436.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-47766952.0,"InventoryRawMaterialsNetOfReserves_0_Q1_USD":2949990.0,"LiabilitiesCurrent_0_Q1_USD":39701710.0,"AccountsPayableCurrent_0_Q1_USD":8720957.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":131379888.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":14494384.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q1_pure":0.948,"ProceedsFromStockOptionsExercised_1_Q1_USD":1431658.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q1_pure":0.21,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss_0_Q1_USD":154000.0,"IssuanceOfStockAndWarrantsForServicesOrClaims_1_Q1_USD":53542.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":78983.0,"NumberOfOperatingSegments_1_Q1_Segment":1.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":1871338.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":69933955.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-989843975.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":4083592.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":5890156.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":15878329.0,"ImpairmentOfLongLivedAssetsHeldForUse_1_Q1_USD":0.0,"OperatingIncomeLoss_1_Q1_USD":-53218693.0,"AllowanceForDoubtfulAccountsReceivable_0_Q1_USD":120000.0,"InventoryNet_0_Q1_USD":7579393.0,"InvestmentIncomeInterest_1_Q1_USD":483750.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":401000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_1_Q1_USD":36.73,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1_Q1_USD":17.82,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q1_USD":20.03,"OperatingLeaseCost_1_Q1_USD":585259.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":6034895.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":5573240.0,"OperatingExpenses_1_Q1_USD":69097022.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-402083.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":9179216.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.65,"ProfitLoss_1_Q1_USD":-52739943.0,"StockholdersEquity_0_Q1_USD":612149758.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":0.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":1085948.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":674488568.0,"ResearchAndDevelopmentExpense_1_Q1_USD":15058168.0,"Ticker":"ITCI","CIK":"1567514","name":"INTRA-CELLULAR THERAPIES, INC.","OfficialName":"Intra-Cellular Therapies Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"5718578003.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]